ArticleBMJ global health2020
National action to combat AMR: a One-Health approach to assess policy priorities in action plans.
Article in BMJ global health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- AMR in wild animals and plants: global trends and future priorities in wildlife-associated antimicrobial resistance research.npj antimicrobials and resistance · 2026Article
- One health rapid qualitative assessment: Exploring local governance gaps in Tanzania.One health (Amsterdam, Netherlands) · 2026Article
- Using implementation science to bridge the gaps between political commitment and action in antimicrobial resistance governance under the one health approach in the WHO Southeast Asia and Western Pacific regions.The Lancet regional health. Western Pacific · 2026Review
- Italy's progress towards the objectives of the national action plan to combat antimicrobial resistance.PloS one · 2026Article
- Policy Makers' Perceptions on Implementation of National Action Plans on Antimicrobial Resistance in South Africa and Eswatini Using Coordination, Accountability, Resourcing, Regulation and Ownership Framework (2018-2019).Antibiotics (Basel, Switzerland) · 2025Article
- One Health implementation: A systematic scoping review using the Quadripartite One Health Joint Plan of Action.One health (Amsterdam, Netherlands) · 2025Review
- Article
- Overcoming barriers to NHS adoption of innovative IPC products: A qualitative study of SMEs in the Liverpool city region.PloS one · 2025Article
- Article
- Soil health: A common focus for one health and planetary health interventions.One health (Amsterdam, Netherlands) · 2024Article
- Knowledge, awareness and practices of healthcare workers regarding antimicrobial use, resistance and stewardship in Zambia: a multi-facility cross-sectional study.JAC-antimicrobial resistance · 2024Article
- Antimicrobial resistance profiles ofJAC-antimicrobial resistance · 2024Article
- Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability.Frontiers in microbiology · 2024Review
- Disposal of Unused Antibiotics in Community Pharmacies in Saudi Arabia: A Mixed-Methods Study.Integrated pharmacy research & practice · 2024Article
- Antibiotic use among hospitalised patients in Sierra Leone: a national point prevalence survey using the WHO survey methodology.BMJ open · 2023Article
- The best laid plans?: international governance perspectives in AMR national action plans in Europe.European journal of public health · 2023Article
- The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: "Attack on Titan".Microorganisms · 2023Review
- Antimicrobial Resistance Policy Protagonists and Processes-A Qualitative Study of Policy Advocacy and Implementation.Antibiotics (Basel, Switzerland) · 2022Article
- Unpacking multi-level governance of antimicrobial resistance policies: the case of Guangdong, China.Health policy and planning · 2022Article
- Understanding the Implementation of Antimicrobial Policies: Lessons from the Hong Kong Strategy and Action Plan.Antibiotics (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Little is known about the overall trend and prioritisations of past and current antimicrobial resistance (AMR) policies. Here we introduce a quantitative method to analyse AMR policies. The AMR-Policy Analysis Coding Toolkit (AMR-PACT) uses several categorical variables. Thirteen AMR action plans from five countries (China, Japan, Norway, the UK and the USA) were used to develop the tool and identify possible values for each variable. The scope and capability of AMR-PACT is demonstrated through the 2015 WHO's Global Action Plan and 2017 Hong Kong AMR Action Plan (HKAP). Majority of policies were aimed at either human or animal sector with less attention given to the environment, plant or food sector. Both plans shared the same two strategic focus areas, namely the conservation of antibiotics and the improved surveillance of resistance. There were no policies dedicated to improving access to antibiotics in the HKAP. These empirical results provide useful insights into the priorities and gaps of AMR policies. The method proposed here can help understand countries' priorities regarding AMR, support the creation of AMR policy database and foster innovative policymaking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.